Enliven Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 73 to 84.

Lowe's LOW had its Relative Strength (RS) Rating upgraded from 62 to 71 Monday — a welcome improvement, but still below the ...

Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Somer G. Anderson is CPA, doctor of accounting, and an accounting ...

As of Thursday, January 08, AeroVironment, Inc.’s AVAV share price has surged by 13.75%, which has investors questioning if ...

The U.S. stock market continues to show strength despite recent concerns over the nation's credit downgrade and fiscal outlook. Over the past few days, major indexes finished higher, driven by ...

The U.S. stock market has been on a remarkable run, with major indexes hitting fresh record highs last week after the Fed delivered its first rate cut of the year. The 25-basis-point reduction, which ...

As of Friday, January 09, Diginex Limited’s DGNX share price has dipped by 8.29%, which has investors questioning if this is ...

In the world of technical analysis, there is one reliable indicator for measuring market risk. The relative strength index measures overextension. Investors commonly use a lookback period of 14 days ...

Forbes contributors publish independent expert analyses and insights. John Navin is a Colorado-based journalist who writes about stocks. The S&P 500 on Friday hit another new high – it was brief as ...